Skip to content

Clinical trials

Mastocytosis, Systemic trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mastocytosis, Systemic Country / region: Belgium Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20191
20201
20212
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting3
Active, not recruiting2
Completed2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Blueprint Medicines Corporation4
Cogent Biosciences, Inc.2
Novartis Pharmaceuticals2
Telios Pharma, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mastocytosis, Systemic9
Leukemia, Mast-Cell3
Hematologic Diseases2
Hypersensitivity2
Immune Complex Diseases2
Immune System Diseases2
Leukemia2
Mastocytosis2
Hematologic Neoplasms1
Hypereosinophilic Syndrome1

Trials

Showing 51 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.